Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants-Reference-Cited by-同舟云学术

Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants

Published:2022-05-07 Issue:2 Volume:21 Page:295-307
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

Ostuzzi Giovanni¹,Bertolini Federico¹,Tedeschi Federico¹,Vita Giovanni¹,Brambilla Paolo²³,Fabro Lorenzo²³,Gastaldon Chiara¹,Papola Davide¹,Purgato Marianna¹,Nosari Guido²³,Del Giovane Cinzia⁴⁵,Correll Christoph U.⁶⁷⁸,Barbui Corrado¹

Affiliation:

1. WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry University of Verona Verona Italy

2. Department of Pathophysiology and Transplantation University of Milan Milan Italy

3. Department of Neurosciences and Mental Health Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy

4. Institute of Primary Health Care University of Bern Bern Switzerland

5. Population Health Laboratory University of Fribourg Fribourg Switzerland

6. Department of Psychiatry Zucker Hillside Hospital Glen Oaks NY USA

7. Department of Psychiatry and Molecular Medicine Zucker School of Medicine at Hofstra/Northwell Hempstead NY USA

8. Department of Child and Adolescent Psychiatry Charité Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Psychiatry and Mental health,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wps.20972

Reference171 articles.

1. Schizophrenia

2. The importance of early treatment of schizophrenia;McEvoy JP;Behav Healthc,2007

3. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

4. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia

5. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis;Psychiatry Research;2024-10

2. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

3. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis;Molecular Psychiatry;2024-08-22

5. Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia;JAMA Network Open;2024-07-17